Notice of Registration - 2012
[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Pages 50162-50163]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20370]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration; Almac
Clinical Services, Inc.
By Notice dated April 17, 2012, and published in the Federal
Register on April 26, 2012, 77 FR 24985, Almac Clinical Services, Inc.,
(ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Tapentadol (9780) |
II |
| Fentanyl (9801) |
II |
The company plans to import small quantities of the listed
controlled substances in dosage form to conduct clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Almac Clinical Services, Inc. (ACSI) to import the
basic classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Almac Clinical Services, Inc. (ACSI) to ensure that the
company's registration is consistent with the public interest.
The investigation has included inspection and testing of the
company's
[[Page 50163]]
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: August 7, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-20370 Filed 8-17-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |